Abstract & Overview
In December 2019, Wuhan, China, witnessed the outbreak of the novel coronavirus (SARS-CoV-2, Table 1), which would soon become an international public health emergency and world pandemic.1 In the United States, we are at a time where preparation for health care systems is critical. Given the rapidity with which SARS-CoV-2 is spreading, we can expect an increased burden of patients with cancer who have received a diagnosis of COVID-19 at oncology treatment clinics and a need to address this diagnosis.